NCT06517888 2026-04-06
Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma
Akouos, Inc.
Phase 1/2 Recruiting
Clinical Trials
7 trialsNCT07503613 2026-04-06
Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy
Akouos, Inc.
Enrolling by invitation
NCT04262336 2023-07-06
Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment
Decibel Therapeutics
Phase 1 Completed
NCT02778295 2023-02-13
BioFabry
CENTOGENE GmbH Rostock
Withdrawn
NCT04132882 2021-09-16
A Compassionate Use Program to Provide Access to Sodium Thiosulfate
TRPHARM
Available
NCT01451853 2017-09-25
SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss
Sound Pharmaceuticals, Incorporated
Phase 2 Unknown
NCT01452607 2016-06-29
Study to Evaluate the Safety and Pharmacokinetics of SPI-1005
Sound Pharmaceuticals, Incorporated
Phase 1 Completed